Sercan Karabulut | Health Professions | Best Scholar Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Sercan Karabulut | Health Professions | Best Scholar Award

Akdeniz University School of Medicine | Turkey

Dr. Sercan Karabulut is an accomplished psychiatrist and academic currently serving at the Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey. He earned his Doctor of Medicine (MD) and completed his Psychiatry Residency at the İstanbul Medicine Faculty, where his scientific interest in the neurobiological mechanisms underlying mental disorders was first cultivated. Over the past decade, he has developed an exceptional academic and clinical career across leading institutions, including Antalya Atatürk State Hospital and Van Bölge Research and Training Hospital, focusing on the diagnosis, treatment, and prevention of psychiatric and substance use disorders. His primary research interests encompass addiction psychiatry, psychotic and mood disorders, neuroinflammation, and methamphetamine-related psychopathology, with a special focus on cognitive impairment and gender-based differences in substance use. Dr. Sercan Karabulut has authored 18 scientific publications, accumulating 195 citations from 193 documents and maintaining an h-index of 5, as indexed in Scopus (ID: 56073897200). His works have appeared in prominent journals, including Acta Neuropsychiatrica, Turkish Journal of Psychiatry, Journal of Drug Issues, and Alpha Psychiatry. Notable studies such as Inflammation and Neurodegeneration in Bipolar Disorder (2019) and Frequency of Methamphetamine Use (2024) have been widely cited and advanced the understanding of neuropsychiatric pathophysiology.

Profile: Scopus | ORCID | ResearchGate

Featured Publications

  1. Karabulut, S., Uzar Uçkun, S., & Genç, H. (2025, October). One year follow-up study of patients with opioid use disorder after inpatient detoxification: Predictors of treatment retention and abstinence. Psychiatry Research. https://doi.org/10.1016/j.psychres.2025.116765

  2. Erdoğan, A., Karabulut, S., Coşkun, M. N., & Tosun, O. (2025, October). Clinical factors associated with craving in patients with opioid use disorder receiving buprenorphine-naloxone maintenance therapy. Journal of Substance Use. https://doi.org/10.1080/14659891.2025.2568066

  3. Bilici, R., Ergelen Yalçın, M., Karabulut, S., & Arpacioglu, S. (2025, September). Validity and reliability study of the Turkish version of the Addiction Severity Index. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 38, 180–186. https://doi.org/10.14744/DAJPNS.2025.00289

  4. Düzgün, M., Erdoğan, A., Karabulut, S., & Şafak, E. (2025, August). The impact of smartphone addiction and social media addiction on traffic safety. Journal of Public Health. https://doi.org/10.1007/s10389-025-02578-y

  5. Karabulut, S., & Uzar Uçkun, S. (2025, June). The association between Theory of Mind, psychopathic traits, borderline personality traits and the severity of substance use disorder in women: A comparative analysis. Alpha Psychiatry, 26(3), 44175. https://doi.org/10.31083/AP44175

 

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Mr. Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

University of the Mountains | Cameroon

Mr. Romaric Tuono De Manfouo is an accomplished biomedical researcher specializing in hematology, infectious diseases, and public health. His work integrates laboratory investigations, epidemiological studies, and translational research to address pressing health challenges in sub-Saharan Africa. With a proven record of impactful scientific contributions, he has been involved in multidisciplinary projects exploring blood disorders, viral infections, and immunological responses. His ability to conduct rigorous clinical studies and collaborate with diverse research teams has positioned him as a respected figure in his field, committed to improving patient care through scientific advancement.

Professional Profile

Scopus

ORCID

Education

Mr. Romaric’s academic journey reflects a strong foundation in health sciences, with a focus on biomedical and clinical research. His studies provided comprehensive training in hematology, immunology, molecular biology, and epidemiology, allowing him to develop the expertise necessary to investigate complex medical conditions. Through extensive research training and practical exposure, he has acquired the skills to design and execute studies that address both laboratory-based and population-level health concerns.

Experience

Throughout his career, Mr. Romaric has worked in academic institutions, research laboratories, and collaborative health projects, contributing to knowledge generation and clinical decision-making. He has been a lead investigator and co-author on studies examining hematological profiles, hemostasis, infectious disease prevalence, and genetic conditions affecting blood health. His experience spans from advanced diagnostic testing to community-based data collection, making his work relevant to both clinical medicine and public health policy.

Research Interest

His research interests center on understanding the mechanisms and epidemiology of blood-related disorders such as sickle cell disease, glucose-6-phosphate dehydrogenase deficiency, and alloimmunization in chronic illness. He is equally engaged in studying infectious diseases including viral hepatitis and their impact on vulnerable populations such as pregnant women, newborns, and high-risk adult groups. His goal is to generate evidence that informs targeted interventions, improves early detection, and enhances patient outcomes in low-resource settings.

Awards

Mr. Romaric’s scientific achievements have been recognized through his publication record, invitations to review for international peer-reviewed journals, and collaborations with multidisciplinary research teams. His expertise is sought after in both academic and clinical research contexts, and his work continues to contribute to advancements in hematology, epidemiology, and public health.

Publications

  • Title: Abnormalities of Hemostasis in Sickle Cell Patients and Predisposition to Thrombotic Risk: A Systematic Review and Meta-Analysis
    Journal: Preprint
    Published on: 2025

  • Title: Inflammation and Iron Profile in Children With Sickle Cell Disease in Cameroon: Frequency and Associated Factors, an Analytical Cross‐Sectional Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Cytopenias and Associated Factors in Patients Living With HIV on ARV Treatment in Cameroon: An Analytical Cross‐Sectional Study
    Journal: Advances in Hematology
    Published on: 2025

  • Title: Haptoglobin Gene Polymorphism and Iron Profile in Sickle Cell Disease Patients With Inflammation in Yaounde, Cameroon
    Journal: Molecular Genetics & Genomic Medicine
    Published on: 2024

  • Title: Hematological And Hemostasis Profile, Thrombotic Risk In Sickle Cell Patient In Cameroon: An Analytical Cross-Sectional Study
    Journal: Hematology and Disorders
    Published on: 2024

  • Title: Hyperuricemia and Associated Factors: The Case of Outpatients at the Bafoussam Regional Hospital-Cameroon, an Analytical Cross-Sectional Study
    Journal: Health Science Reports
    Published on: 2024

Conclusion

Mr. Romaric Tuono De Manfouo exemplifies excellence in biomedical research, combining academic rigor, clinical insight, and a commitment to public health. His body of work reflects a consistent focus on improving the understanding, diagnosis, and management of hematological and infectious diseases in African populations. Through his scholarly publications, peer-review contributions, and research leadership, he continues to make significant contributions that enhance scientific knowledge and healthcare delivery. His achievements make him a worthy nominee for the Best Researcher Award, representing dedication, innovation, and scientific integrity.